Skip to main content
Erschienen in: European Journal of Nutrition 5/2022

16.03.2022 | Original Contribution

Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study

verfasst von: Yahya Mahamat-Saleh, Isabelle Savoye, Iris Cervenka, Marie Al-Rahmoun, Claire Cadeau, Marie-Christine Boutron-Ruault, Marina Kvaskoff

Erschienen in: European Journal of Nutrition | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Experimental studies suggested that antioxidants could protect against skin carcinomas. However, epidemiological studies on antioxidant supplement use in relation to basal-cell carcinoma (BCC) and squamous-cell carcinoma (SCC) risks yielded inconsistent findings, and few prospective studies have been conducted to date. We aimed to investigate the associations between antioxidant supplement intake and keratinocyte cancer (KC) risk.

Methods

E3N is an ongoing prospective cohort initiated in 1990 and involving 98,995 French women aged 40–65 years at recruitment. Intakes of dietary antioxidants were estimated via a validated dietary questionnaire in 1993 and self-reported antioxidant supplement use was collected in 1995. We used Cox models to compute hazard ratios (HRs) and 95% confidence intervals (CIs) adjusted for age and skin cancer risk factors.

Results

Over 1995–2014, 2426 BCC and 451 SCC cases were diagnosed among 63,063 women. We found positive relationships between vitamin A supplement use and KC risk (HR = 1.37, 95% CI 1.15–1.62), particularly with BCC (HR = 1.40, 95% CI 1.17–1.69); and between vitamin E supplement use and risks of both BCC (HR = 1.21, 95% CI 1.03–1.52) and SCC (HR = 1.43, 95% CI 1.03–1.99). Intake of beta-carotene supplements was associated with an increased SCC risk (HR = 1.59, 95% CI 1.00–2.54). Vitamin C supplement use was not associated with KC risk. We found similar results when considering total antioxidant intake.

Conclusions

Intakes of vitamin A or E supplements were associated with an increased KC risk in women. Further studies with information on doses and duration of supplement use and the ability to examine their underlying mechanisms are needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Urbach F (1991) Incidence of nonmelanoma skin cancer. Dermatol Clin 9:751–755CrossRef Urbach F (1991) Incidence of nonmelanoma skin cancer. Dermatol Clin 9:751–755CrossRef
3.
Zurück zum Zitat Staples MP, Elwood M, Burton RC et al (2006) Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184:6–10CrossRef Staples MP, Elwood M, Burton RC et al (2006) Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184:6–10CrossRef
5.
Zurück zum Zitat Joseph AK, Mark TL, Mueller C (2001) The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27:955–959PubMed Joseph AK, Mark TL, Mueller C (2001) The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27:955–959PubMed
10.
Zurück zum Zitat Gupta S, Mukhtar H (2002) Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev 21:363–380CrossRef Gupta S, Mukhtar H (2002) Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev 21:363–380CrossRef
11.
Zurück zum Zitat Pauling L (1991) Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice. Am J Clin Nutr 54:1252S-1255SCrossRef Pauling L (1991) Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice. Am J Clin Nutr 54:1252S-1255SCrossRef
12.
Zurück zum Zitat Robinson AB, Hunsberger A, Westall FC (1994) Suppression of squamous cell carcinoma in hairless mice by dietary nutrient variation. Mech Ageing Dev 76:201–214CrossRef Robinson AB, Hunsberger A, Westall FC (1994) Suppression of squamous cell carcinoma in hairless mice by dietary nutrient variation. Mech Ageing Dev 76:201–214CrossRef
15.
Zurück zum Zitat van Dam RM, Huang Z, Giovannucci E et al (2000) Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 71:135–141CrossRef van Dam RM, Huang Z, Giovannucci E et al (2000) Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 71:135–141CrossRef
17.
Zurück zum Zitat Davies TW, Treasure FP, Welch AA, Day NE (2002) Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. Br J Dermatol 146:1017–1022CrossRef Davies TW, Treasure FP, Welch AA, Day NE (2002) Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. Br J Dermatol 146:1017–1022CrossRef
18.
Zurück zum Zitat Frieling UM, Schaumberg DA, Kupper TS et al (2000) A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician’s health study. Arch Dermatol 136:179–184CrossRef Frieling UM, Schaumberg DA, Kupper TS et al (2000) A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician’s health study. Arch Dermatol 136:179–184CrossRef
27.
Zurück zum Zitat Hercberg S, Ezzedine K, Guinot C et al (2007) Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137:2098–2105CrossRef Hercberg S, Ezzedine K, Guinot C et al (2007) Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137:2098–2105CrossRef
28.
Zurück zum Zitat Savoye I, Cadeau C, Cervenka I et al. Does solar supplement use increase skin cancer risk? Accept Publ Savoye I, Cadeau C, Cervenka I et al. Does solar supplement use increase skin cancer risk? Accept Publ
30.
Zurück zum Zitat Centre de Recherche pour l’Etude et l’Observation des Conditions de vie (CREDOC) (2010) Consommation de compléments alimentaires en France. Exploitation de l’enquête INCA2 par le CREDOC at http://www.credoc.fr Centre de Recherche pour l’Etude et l’Observation des Conditions de vie (CREDOC) (2010) Consommation de compléments alimentaires en France. Exploitation de l’enquête INCA2 par le CREDOC at http://​www.​credoc.​fr
32.
Zurück zum Zitat Favier J, Ireland-Ripert J, Toque C, Feinberg M (1995) Répertoire Général des Aliments. Table de composition (General repertory of foods. Composition tables). Paris Fr Favier J, Ireland-Ripert J, Toque C, Feinberg M (1995) Répertoire Général des Aliments. Table de composition (General repertory of foods. Composition tables). Paris Fr
33.
Zurück zum Zitat van Liere MJ, Lucas F, Clavel F et al (1997) Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol 26(Suppl 1):S128-136CrossRef van Liere MJ, Lucas F, Clavel F et al (1997) Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol 26(Suppl 1):S128-136CrossRef
37.
Zurück zum Zitat Steinmetz KA, Potter JD (1991) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325–357CrossRef Steinmetz KA, Potter JD (1991) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325–357CrossRef
40.
Zurück zum Zitat Wei Q, Matanoski GM, Farmer ER et al (1994) Vitamin supplementation and reduced risk of basal cell carcinoma. J Clin Epidemiol 47:829–836CrossRef Wei Q, Matanoski GM, Farmer ER et al (1994) Vitamin supplementation and reduced risk of basal cell carcinoma. J Clin Epidemiol 47:829–836CrossRef
42.
Zurück zum Zitat Breslow RA, Alberg AJ, Helzlsouer KJ et al (1995) Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomark Prev 4:837–842 Breslow RA, Alberg AJ, Helzlsouer KJ et al (1995) Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomark Prev 4:837–842
43.
Zurück zum Zitat Fung TT, Hunter DJ, Spiegelman D et al (2002) Vitamins and carotenoids intake and the risk of basal cell carcinoma of the skin in women (United States). Cancer Causes Control 13:221–230CrossRef Fung TT, Hunter DJ, Spiegelman D et al (2002) Vitamins and carotenoids intake and the risk of basal cell carcinoma of the skin in women (United States). Cancer Causes Control 13:221–230CrossRef
45.
Zurück zum Zitat Sies H, Stahl W (1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62:1315S-1321SCrossRef Sies H, Stahl W (1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62:1315S-1321SCrossRef
46.
Zurück zum Zitat Burton GW, Ingold KU (1984) beta-Carotene: an unusual type of lipid antioxidant. Science 224:569–573CrossRef Burton GW, Ingold KU (1984) beta-Carotene: an unusual type of lipid antioxidant. Science 224:569–573CrossRef
48.
Zurück zum Zitat Pearson P, Lewis SA, Britton J et al (2006) The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs 20:271–273CrossRef Pearson P, Lewis SA, Britton J et al (2006) The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs 20:271–273CrossRef
51.
Metadaten
Titel
Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study
verfasst von
Yahya Mahamat-Saleh
Isabelle Savoye
Iris Cervenka
Marie Al-Rahmoun
Claire Cadeau
Marie-Christine Boutron-Ruault
Marina Kvaskoff
Publikationsdatum
16.03.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 5/2022
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-022-02861-8

Weitere Artikel der Ausgabe 5/2022

European Journal of Nutrition 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.